glp-1 and ocd GLP-1s were designed for diabetes weight loss, but researchers are now exploring whether they may also affect the brain., Early studies suggest medications could influence reward pathways, GLP-1 actions and target organs.

In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

Viewing addiction purely as a reward-driven problem would be an oversimplification, he said, stressing the need for a multidisciplinary approach while researchers continue to explore whether these medications could play a meaningful supportive role in the future

Culinary medicine and culinary nutrition education for individuals with the capacity to influence health-related behavior change: a scoping review

Figure 6)

By doing so, these injectables assist in weight loss by reducing cravings and promoting a feeling of fullness after eating smaller portions

If you experience symptoms like leg pain, we are here to help you determine if it is a sign you need more hydration, a shift in your diet, or a consultation with one of our specialists